Please wait
Healthcare · Medical Instruments & Supplies · Price, fundamentals, signals, and forward-looking context in one research view.
Healthcare
$51.6B
2.2%
32.56
Current price
$189.52
0.0% todayUpdated 7h ago
Open
$188.04
Previous close
$189.52
Day range
$187.54 – $190.32
Volume
N/A
32.6x P/E
Awaiting filing
2.2% yield
65/100 measured
Easy to trade
Recent price movement, key market context and the latest company information.
The latest saved price history for BDX, with its range and direction at a glance.
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments. It provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow system, automated medication dispensing and supply management systems, informatics and analytics and pharmacy automation system, and medication inventory optimization and tracking system; hemodynamic monitoring system; and prefillable drug delivery systems. It also offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, and microorganism identification and drug susceptibility, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent system, and solution for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. It provides hernia and soft tissue repair, biological and bioresorbable graft, biosurgery, and other surgical products; surgical infection prevention, peripheral intervention, and urology and critical care products. The company has a strategic collaboration with ChemoGLO for the advancement of hazardous drug contamination testing in health care settings to improve the safety of health care workers. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.
Investors usually follow BDX for its dividend profile, valuation signal, sector position, and upcoming company events. The goal here is not just to show numbers, but to explain what they mean in plain English.
Whisone is bullish because fundamentals are solid at 71/100 while there is no strong bear warning from the current data. Whisone has moderate conviction here. The final read is being balanced by the weighted scores for fundamentals, technicals, insider flow, sentiment, event flow, and liquidity.
Whisone v2 splits the read into weighted parts so the score is not just one hidden number.
Fundamentals
Growth, margins, cash flow, and valuation.
Latest net profit
$377M
TTM (2026-06-30)
ROE
6.6%
Return on equity
ROA
4.3%
Return on assets
Debt / equity
0.69
Lower is usually safer.
P/B ratio
2.11
Useful for book value support.
Dividend yield
2.2%
Current income signal.
85/100
Direction
Range-bound
Main supports
Business quality and balance-sheet strength are supporting the outlook.
Recent price behavior and momentum still support follow-through.
Recent price and fundamentals refreshes improve signal reliability.
What can go wrong
Execution risk and market swings can still delay the forecast playing out.
Fair value
$191.97
Analyst view
Buy
Analyst target
$194.42
Forecast refresh
Updated 7h ago
Quality score
70
Growth score
50
These are the external analyst numbers and business outlook figures already synced into the company record.
No external analyst outlook is available for this company yet.
$0.82
2024-12-09
Payment: TBA | Qualification: 2024-12-09 | Yield at declaration: N/A
$0.75
2024-09-09
Payment: TBA | Qualification: 2024-09-09 | Yield at declaration: N/A
A plain-English reading of momentum, trend, volatility, range position, and trading participation.
RSI
N/A
Momentum data is not available yet.
Recent trend
Rising
+14.4% across the latest saved price window.
Volatility
Low
Beta is 0.26. Price has historically moved more calmly than the wider market.
52-week position
95% of range
Price is trading close to its 52-week high.
Volume confirmation
N/A
Comparable volume data is not available.
Sector spillover signals
No sector spillover signal has been linked yet.
BDX
Becton, Dickinson and Company
Price: $189.52
P/E: 32.563572
Yield: 2.2%
ABBV
AbbVie Inc.
Price: $256.22
P/E: 72.994286
Yield: 2.7%
ABT
Abbott Laboratories
Price: $110.02
P/E: 36.39806
Yield: 2.3%
ALGN
Align Technology, Inc.
Price: $158.16
P/E: 27.310226
Yield: 0.0%
Industry
Medical Instruments & Supplies
Employees
72000
Exchange
NYQ
Ticker
BDX
